Replimune (REPL) Debt Ratio (2019 - 2026)

Replimune (REPL) reported Debt Ratio of 0.25 for Q1 2026, up 197.95% on a YoY basis from 0.08 in Q1 2025, and up 75.55% sequentially from 0.14 in Q4 2025.

Replimune (REPL) Debt Ratio (2019 - 2026) Analysis & Trends

Replimune (REPL) has 7 years of Debt Ratio data on file, last reported at 0.25 in Q1 2026.

  • For the quarter ending Q1 2026, Debt Ratio rose 197.95% year-over-year to 0.25; the trailing twelve-month figure through Mar 2026 stood at 0.25 (up 197.95% YoY), and the FY2026 full-year result was 0.25, up 197.95% from the prior year.
  • Debt Ratio grew to 0.25 in Q1 2026, from 0.14 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.25 in Q1 2026 to a low of 0.04 in Q4 2022.
  • A 5-year average of 0.09 and a median of 0.08 in 2024 frame the typical range for Debt Ratio.
  • Across the five-year window, Debt Ratio retreated 8.68% in 2024 and jumped 197.95% in 2026, its largest moves.
  • Tracing REPL's Debt Ratio over 5 years: stood at 0.04 in 2022, then jumped by 99.28% to 0.08 in 2023, then retreated by 8.68% to 0.08 in 2024, then surged by 87.52% to 0.14 in 2025, then soared by 75.55% to 0.25 in 2026.
  • Business Quant data shows REPL's Debt Ratio at 0.25 in Q1 2026, 0.14 in Q4 2025, and 0.12 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 1.41
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.11
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.05
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Replimune 970.73 Mn 970.73 Mn - 0.25

Historic Data

Download Data
DateValue
Mar 31, 2026 0.25
Dec 31, 2025 0.14
Sep 30, 2025 0.12
Jun 30, 2025 0.10
Mar 31, 2025 0.08
Dec 31, 2024 0.08
Sep 30, 2024 0.09
Jun 30, 2024 0.08
Mar 31, 2024 0.09
Dec 31, 2023 0.08
Sep 30, 2023 0.05
Jun 30, 2023 0.05
Mar 31, 2023 0.04
Dec 31, 2022 0.04
Sep 30, 2020 0.03
Jun 30, 2020 0.03
Mar 31, 2020 0.04
Dec 31, 2019 0.04
Sep 30, 2019 0.06